| Dr Paul A Stangl, MD | |
|
2045 N Franklin St, Denver, CO 80205-5437 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Paul A Stangl |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 2045 N Franklin St, Denver, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114916921 | NPI | - | NPPES |
| 02667105 | Medicaid | NY | |
| 020701 | Other | CO | KAISER COMMERCIAL NUMBER |
| 67137334 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 236284 (New York) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 48492 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Hospital | Denver, CO | Hospital |
| Good Samaritan Medical Center Llc | Lafayette, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
| Saint Joseph Hospital, Inc | 6204735970 | 10 |
| Good Samaritan Medical Center, Llc | 7618995275 | 7 |
News Archive
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.
› Verified 5 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.
› Verified 5 days ago
| Entity Name | Saint Joseph Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154361350 PECOS PAC ID: 6204735970 Enrollment ID: O20040102000258 |
News Archive
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.
› Verified 5 days ago
| Entity Name | Good Samaritan Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043250780 PECOS PAC ID: 7618995275 Enrollment ID: O20051102001154 |
News Archive
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul A Stangl, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Paul A Stangl, MD 2045 N Franklin St, Denver, CO 80205-5437 Ph: (303) 338-4545 |
News Archive
Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.
Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.
According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."
University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.
› Verified 5 days ago
Dr. Manuel D Aquino, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9400 E Iliff Ave Apt 41, Denver, CO 80231 Phone: 720-934-4537 | |
Dr. Robert Ward Burman, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. John H Bair, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2045 Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Gary W. Bauerle, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 938 Bannock St, Ste 300, Denver, CO 80204 Phone: 303-914-8800 Fax: 303-716-3777 | |
Dr. Sara Louise Anschuetz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2490 W 26th Ave, Suite 220, Denver, CO 80211 Phone: 303-433-9729 Fax: 303-480-0405 | |
Dr. Jeffrey D Wicks, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2490 W 26th Ave, Suite 220, Denver, CO 80211 Phone: 303-433-9729 Fax: 303-480-0405 | |
Christopher Ryan Deig, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1721 E 19th Ave, #520, Denver, CO 80218 Phone: 812-449-1243 |